History
Company History
About Us
Introduction
History
Endless Innovation
Endless Advancement
PEPGENE constantly strives to become a leading player in the peptide biosimilar market.
06
Technology commercialization capacity building from Ministry of Science and ICT
GMP manufacturing of teriparatide biosimilar for IND application
05
Development of cleavage enzyme with improved solubility for recombinant production of liraglutide precursor peptide
Development and validation of GLP-1 analogue for diabetes and obesity
04
Industry-academia convergence R&D support project from Chungbuk Province
Development of cleavage enzyme with improved solubility for recombinant production of liraglutide precursor peptide
04
Regional flagship development project from Ministry of SMEs and Startups
Development of recombinant production process and biosimilarity analytical methods of teduglutide for treating short bowel syndrome
04
USA patent registration (1 cases)
03
BIG3 Innovation startup package form Ministry of SMEs and Startups
Recombinant production and non-clinical study of peptide for the treatment of short bowel syndrome using HYPER technology
12
Patent registration (3 cases)
09
Patent registration (3 cases)
06
Technology commercialization capacity building project from Ministry of Science and ICT
Nonclinical GLP toxicology study of teriparatide biosimilar
05
Startup leap package support project from Ministry of SMEs and Startups
Development of peptide biopharmaceutical Biosimilar (Teriparatide, Liraglutide, Teduglutide)
03
Base technology construction project from Kbio health
Analytical methods development of physicochemical and biobiological identity for teduglutide biosimilar for short bowel syndrome
08
Advanced medical technology value creation project from Chungbuk Province
Investigation for in-vivo biosimilarity of Teriparatide biosimilar on osteoporosis using ovariectomized rats
05
Regional flagship development project from Ministry of SMEs and Startups
Recombinant production and biosimilarity study of teriparatide biosimilar for osteoporosis
05
New research recruitment support project from Ministry of SMEs and Startups
Development of acylation process for the production of liraglutide biosimilar for diabetes and obesity
Development of the fusion partner for the production of peptide biopharmaceutical biosimilar
03
Patent registration (1 case)
12
Korean Excellent Patent Award (Biotechnology/chemistry) (Grand Prize)
10
Certification of research institute
08
Patent registration (4 cases)
08
Establishment of R&D center (Pangyo)
08
T&K Bioinnovation M&A
05
TIPS Startup commercialization funding support project from Ministry of SMEs and Startups
Development of the production process of liraglutide precursor peptide for production of trial product
12
Korea Biopharmaceutical Award (Grand Prize)
12
TIPS program from Ministry of SMEs and Startups
Development of liraglutide biosimilar with global price competitiveness
06
Startup commercialization support project from Ministry of SMEs and Startups
Development of recombinant E. coli system for production of the peptide for the treatment of diabetes
04
Venture business certification (20180103989)
05
Startup Accelerating Program from Chungbuk Creative Economy Innovation center
03
Establishment of PEPGENE inc (2017.03.06)